Konferencija povodom obilježavanja Dana kliničkih ispitivanja, 20. maja
The second event in the series focusing on the digital transformation of diabetes care, co-organised by the EFPIA Diabetes Platform and IDF Europe.
Međunarodna konferencija “Biološki i biološki slični lijekovi”, Banja Luka, 10. maj 2017.
Na Medicinskom fakultetu UNSA održana radionica o neželjenim učincima lijekova
Regulirana farmaceutska udruženja znače bolju kontrolu nad tržištem lijekova od strane države
Introducing the EFPIA Disclosure Code
EFPIA believes that interactions between the pharmaceutical industry and healthcare professionals have a profound and positive influence on the quality of patient treatment and the value of future research.
At the same time, the integrity of the decision of a healthcare professional to prescribe or recommend a medicine is one of the pillars of the healthcare system. EFPIA recognises that interactions between the industry and healthcare professionals can create the potential for conflicts of interest.